Ibi Inv House (IBI) AI Stock Analysis

• Market Cap: 4.74B
• Dividend Yield: 3.92%
• Average Volume (3M): 16.58K
• Price to Earnings (P/E): 31.5
• Beta (1Y): 0.86
• Revenue Growth: 46.14%
• EPS Growth: -17.83%
• Country: IL
• Employees: 937
• Sector: Financial
• Sector Strength: 70
• Industry: Financial - Conglomerates
• EPS (TTM): 333.30
• Shares Outstanding: 13,998,051
• 10 Day Avg. Volume: 11,015
• 30 Day Avg. Volume: 16,583
• PEG Ratio: 1.76
• Price to Book (P/B): 2.31
• Price to Sales (P/S): 2.00
• P/FCF Ratio: 9.51
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: 37,946.00 ▲(28.24% Upside)

Ibi Inv House's strong financial performance and positive technical indicators are the primary drivers of its overall stock score. While the valuation suggests the stock may be expensive, the solid dividend yield offers some compensation. The lack of earnings call data and corporate events does not impact the score due to their exclusion.

Positive Factors

High revenue growth and margins

Sustained double-digit revenue growth combined with very high gross and robust operating margins indicates durable core profitability. This supports continued reinvestment in deal sourcing and fund operations, bolstering long-term earnings power and cash available for stakeholders.

Strong free cash flow growth

Rapid FCF expansion signals improving ability to self-fund investments, distributions and capital allocation without heavy reliance on external financing. Over time positive FCF growth increases strategic flexibility to grow AUM, support portfolio companies, and sustain dividends or buybacks.

Moderate leverage and solid equity base

A low debt-to-equity ratio and a strong equity ratio provide balance-sheet resilience and capacity to absorb shocks. Healthy ROE shows effective capital deployment. Together these metrics underpin long-term financial flexibility to pursue opportunities and withstand cyclical stress.

Negative Factors

Negative EPS growth

Declining EPS despite revenue gains suggests pressures from non-operating items, dilution, or realized losses in investments. Persistent EPS contraction can erode shareholder returns and signal weaker core earnings per share generation over the medium term if not addressed.

Low operating cash conversion

OCF converting at only ~34% of net income points to earnings quality or timing issues, with income not fully translating into ongoing operating cash. Over months this raises questions about liquidity reliability for funding operations without relying on asset sales or irregular cash inflows.

Revenue concentration and AUM sensitivity

Business is structurally tied to AUM levels and realized investment performance. Market downturns or weak exit markets can materially reduce management and performance fees. This creates cyclical revenue variability and dependence on fundraising and deal exits for sustained fee growth.

Ibi Inv House Business Overview & Revenue Model

Company Description

Ibi Inv House (IBI) is a diversified investment firm specializing in asset management, private equity, and venture capital. The company operates across various sectors, including technology, healthcare, real estate, and renewable energy, providing a comprehensive range of financial services. IBI focuses on identifying high-potential investment opportunities and offers tailored financial solutions to both institutional and retail clients, including fund management, advisory services, and wealth management.

How the Company Makes Money

Ibi Inv House generates revenue primarily through management fees charged on the assets under management (AUM) in its various investment funds. Additionally, the company earns performance fees based on the profits generated from its investments, particularly in private equity and venture capital. Key revenue streams also include advisory fees from corporate clients seeking strategic insights and investment guidance. IBI has established significant partnerships with financial institutions and other investment firms, enhancing its market reach and investment capabilities, which contribute to its overall earnings. Furthermore, IBI capitalizes on investment exit strategies such as IPOs and mergers and acquisitions, which provide substantial returns and boost its revenue.

Ibi Inv House Financial Statement Overview

Summary

Ibi Inv House demonstrates strong profitability with high margins, but faces challenges due to a significant revenue decline and negative free cash flow growth in the TTM. The company maintains a balanced leverage position and a solid equity base.

Income Statement

Ibi Inv House shows strong profitability with a high gross profit margin of 95.99% and a net profit margin of 23.57% in the TTM. However, the company experienced a significant revenue decline of 32.45% in the TTM, which is a concern. Despite this, EBIT and EBITDA margins remain robust at 54.86% and 66.30%, respectively, indicating efficient operations.

Balance Sheet

The company maintains a moderate debt-to-equity ratio of 0.35, suggesting a balanced approach to leverage. Return on equity is healthy at 15.58%, reflecting effective use of equity to generate profits. The equity ratio stands at 44.08%, indicating a solid equity base relative to total assets.

Cash Flow

Cash flow analysis reveals a decline in free cash flow growth by 30.70% in the TTM, which is concerning. The operating cash flow to net income ratio is 0.34, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is 0.78, showing decent cash conversion.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	693.61M	1.04B	791.55M	660.61M	548.65M	435.79M
Gross Profit	671.10M	696.21M	511.24M	417.09M	357.00M	279.51M
EBITDA	407.72M	368.28M	281.08M	212.29M	227.69M	150.50M
Net Income	146.12M	178.14M	156.46M	90.76M	139.58M	81.94M
Balance Sheet
Total Assets	2.09B	1.85B	1.27B	1.08B	1.13B	1.02B
Cash, Cash Equivalents and Short-Term Investments	603.89M	519.23M	453.00M	246.53M	547.09M	530.66M
Total Debt	303.18M	243.90M	201.26M	154.42M	334.90M	197.25M
Total Liabilities	972.93M	750.27M	539.07M	399.48M	521.39M	469.80M
Stockholders Equity	891.39M	899.76M	686.62M	640.44M	575.47M	522.10M
Cash Flow
Free Cash Flow	209.21M	218.35M	207.56M	45.23M	190.60M	68.70M
Operating Cash Flow	244.07M	249.28M	269.65M	61.11M	197.55M	79.24M
Investing Cash Flow	-117.41M	-97.88M	-269.38M	-44.08M	36.90M	-83.84M
Financing Cash Flow	-70.00M	-141.00K	-37.48M	-80.76M	-196.36M	24.85M

Ibi Inv House Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 29590.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Positive. The current price of 29590 is below the 20-day moving average (MA) of 31002.00, above the 50-day MA of 28319.17, and above the 200-day MA of 24209.07, indicating a bullish trend. The MACD of 1555.51 indicates Negative momentum. The RSI at 75.00 is Negative, neither overbought nor oversold. The STOCH value of 96.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IBI	74 Outperform	4.74B	31.53	―	3.92%	46.14%	-17.83%
ATRY	73 Outperform	1.27B	11.95	―	6.06%	687.69%	21.73%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
IDIN	60 Neutral	3.58B	10.40	―	5.98%	19.48%	53.61%